Clinical Trials Insight: 700023565

Trial Profile

Clinical Trials Insight: 700023565

Not stated
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2008

At a glance

  • Drugs GRC 6211 (Primary)
  • Indications Musculoskeletal pain; Neuropathic pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Glenmark Pharmaceuticals S.A.
  • Most Recent Events

    • 24 Oct 2008 Clinical development of GRC 6211 in osteoarthritis has been suspended.
    • 05 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top